Biohaven (NYSE:BHVN) stock gains on tumor-shrinking results for the company's cancer drug BHV-1510 with Regeneron's (REGN) ...

Urothelial carcinoma is cancer of the urinary system. The urothelium is a kind of epithelial (protective) lining of the urinary system, which includes the urinary tract, bladder, your ureters (the ...

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will ...

CheckMate 274 is a phase III, randomized, double-blind trial of adjuvant nivolumab versus placebo for muscle-invasive urothelial carcinoma (MIUC) at high risk of recurrence after radical resection.

AI enhances urothelial carcinoma diagnosis and management, but only as an assistive tool, not a replacement, for ...

USA-based UroGen Pharma, a biotech developing and commercializing innovative solutions that treat urothelial and specialty ...

Analyst Selvaraju downgrades UroGen after FDA panel setback dims approval prospects for key bladder cancer drug UGN-102.

Company to present interim update from ENLIGHTED Phase 3 Study in LG UTUC following assessment of 50% of targeted total ...

The following is a summary of “Impact of concomitant medications on the oncologic efficacy of systemic therapy in patients ...

Inshan Ishmael has been a familiar voice and face in Trinidad and Tobago—fearless, outspoken, and passionate, whether as a ...